Searches , social queries for SARILUMAB
Search references for SARILUMAB. Phrases containing SARILUMAB
See searches and references containing SARILUMAB!
Search references for SARILUMAB. Phrases containing SARILUMAB
See searches and references containing SARILUMAB!SARILUMAB
Human monoclonal antibody medication
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals
Sarilumab
Drugs to suppress IL-6 signalling
pathway by gefitinib tumor growth was decreased both in vitro and in vivo. Sarilumab was approved by US FDA in 2017 for rheumatoid arthritis. Several agents
Anti-interleukin-6
American biotechnology company
FDA in March 2017 and is reported to cost $37,000 per year. Kevzara (sarilumab injection) is an interleukin-6 (IL-6) receptor antagonist for treatment
Regeneron_Pharmaceuticals
French multinational pharmaceutical and healthcare company
Pharmaceuticals. Jevtana (Cabazitaxel), for prostate cancer. Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron. Libtayo
Sanofi
Inflammation of the stomach lining
COVID-19 treatment have also been found to cause gastritis; tocilizumab and sarilumab are associated with chronic gastritis, while lopinavir/ritonavir is associated
Gastritis
Drug used to treat allergic diseases
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Dupilumab
Mammalian protein found in Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_23_subunit_alpha
Heterodimeric cytokine acting as mediator of inflammation
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_23
Chemical compound
rescue therapy in a patient with COVID-19 with no complete response to sarilumab". Infection. 48 (5): 767–771. doi:10.1007/s15010-020-01476-7. PMC 7340855
Baricitinib
Medication used to treat autoimmune diseases
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Ixekizumab
Medical condition
current clinical trial in the United Kingdom that involves the use of Sarilumab injections for the treatment of musculoskeletal and connective tissue
SCARF_syndrome
Monoclonal antibody
Namilumab Nipocalimab Oleclumab Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation:
Theralizumab
Group of proteins
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_17
Protein found in humans
differentiation Anti-IL-6 Tocilizumab, a monoclonal antibody against IL6R Sarilumab, a monoclonal antibody against IL6R LMT-28, a small molecule antagonist
Interleukin-6_receptor
Biopharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Ustekinumab
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Anakinra
Monoclonal antibody against IL-17
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Secukinumab
Mammalian protein found in Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_1_beta
Monoclonal antibody medication
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Mepolizumab
Category of drugs
rituximab chimeric monoclonal antibody against CD20 on B-cell surface bDMARD sarilumab IL-6 receptor antagonist bDMARD secukinumab IL-17 inhibitor bDMARD sulfasalazine
Disease-modifying antirheumatic drug
Disease-modifying_antirheumatic_drug
Mammalian protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_2
Form of immunotherapy
intravenous humanized TROP-2 triple-negative breast cancer 761115 Link sarilumab Kevzara Sanofi Aventis 5/22/2017 subcutaneous fully human IL6R rheumatoid
Monoclonal_antibody_therapy
Drug repurposing research related to COVID-19
Service issued guidance that the immune modulating drugs tocilizumab and sarilumab were beneficial when given promptly to people with COVID-19 admitted to
COVID-19 drug repurposing research
COVID-19_drug_repurposing_research
British medical professor
trial to demonstrate that the immune modulating drugs, tocilizumab and sarilumab, saved lives from severe COVID-19. The Prime Minister announced this result
Anthony Gordon (clinical scientist)
Anthony_Gordon_(clinical_scientist)
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL13RA2
Investigational fatigue drugs
selegiline) Monoclonal antibodies (e.g., adalimumab, infliximab, golimumab, sarilumab, tocilizumab, secukinumab) Norepinephrine reuptake inhibitors (NRIs) (e
List of investigational fatigue drugs
List_of_investigational_fatigue_drugs
Receptors on the surface of cells
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Type_I_cytokine_receptor
Pharmaceutical compound
other interleukin receptors will be developed in future. IL-4-inhibitor-1 Sarilumab Tocilizumab Hong SS, Choi JH, Lee SY, Park YH, Park KY, Lee JY, et al
LMT-28
Mammalian cytokine
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_40
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Guselkumab
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Pacibekitug
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL12A
Immunosuppressive drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Tocilizumab
Marker on immune cells
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
CD4
saralasin (INN) sarcolysin (INN) saredutant (INN) Sarenin sargramostim (INN) sarilumab (USAN) saripidem (INN) Sarisol sarizotan (USAN) sarmazenil (INN) sarmoxicillin
List_of_drugs:_S–Sd
Member of the interleukin 1 receptor family
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
ST2_cardiac_biomarker
Pharmaceutical drug classification
Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab
ATC_code_L04
Mammalian protein found in Mus musculus
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_4
Anti-inflammatory cytokine
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_10
Cytokine protein
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_6
Chemical compound
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Clazakizumab
CD200 cancer Samrotamab vedotin mab chimeric/ humanized LRRC15 cancer Sarilumab Kevzara mab human IL-6 Y rheumatoid arthritis, ankylosing spondylitis
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Benralizumab
Overview of and topical guide to immunology
Bimekizumab Briakinumab Brodalumab Canakinumab Daclizumab Netakimab Olokizumab Sarilumab Satralizumab Secukinumab Siltuximab Sirukumab Spesolimab Tocilizumab Interleukin
Outline_of_immunology
Mammalian protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_8
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL1RL2
Interleukin
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_12
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin 10 receptor, beta subunit
Interleukin_10_receptor,_beta_subunit
Growth factor secreted by stromal cells in the bone marrow and thymus
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_7
Mammalian protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_21
Group of cytokines
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin
Cytokine receptor which binds interleukin 1
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-1_receptor
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Lebrikizumab
Group of cytokine proteins
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-1_family
Drug class
Examples: Anakinra Tocilizumab Canakinumab Secukinumab Ustekinumab Ixekizumab Sarilumab Selective costimulation modulator of T cells is a type of biologic that
Antiarthritics
Lymphocyte receptor specific for Interleukin-2
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL-2_receptor
COVID-19 in the UK: Two anti-inflammatory medications, tocilizumab and sarilumab, are found to cut deaths by a quarter in patients who are sickest with
2021_in_the_United_Kingdom
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_1-alpha
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Siltuximab
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Tildrakizumab
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Canakinumab
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-12_subunit_beta
Cytokine with structural similarity to Interleukin-2
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_15
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Inolimomab
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_11
Protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_24
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin 15 receptor, alpha subunit
Interleukin_15_receptor,_alpha_subunit
Protein in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_31
Cell surface receptor for interleukin-10
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-10_receptor
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Reslizumab
Protein involved in immune suppression
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_35
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Oprelvekin
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Basiliximab
Protein-coding gene in the species Homo sapiens
Etanercept Certolizumab Inflixamab Inflectra Interleukin 6 Tocilizumab Sarilumab Janus Kinase Tofacitnib Upadacitinib Baricitinib Ruxolitinib Fedratinib
YWHAH
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Tralokinumab
Protein and coding gene in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-1 receptor antagonist
Interleukin-1_receptor_antagonist
Protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin 12 receptor, beta 2 subunit
Interleukin_12_receptor,_beta_2_subunit
Group of anti-viral cytokines
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interferon_type_III
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL1RAP
Medication
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Rilonacept
Cell surface receptors for interleukin-13
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-13_receptor
Protein that in humans is encoded by the IL33 gene
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_33
Immunoglobulin superfamily
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-1_receptor_family
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Daclizumab
Type of cytokine
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_5
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-4_receptor
Monoclonal antibody
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Olokizumab
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
IL18BP
Protein and coding gene in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin 12 receptor, beta 1 subunit
Interleukin_12_receptor,_beta_1_subunit
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-21_receptor
Pharmaceutical drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Denileukin_diftitox
Monoclonal antibody drug
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Tucotuzumab_celmoleukin
Type I cytokine receptor
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-12_receptor
Transmembrane proteins
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Type_II_cytokine_receptor
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interferon_lambda_3
Protein found in humans
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_19
Type of protein receptor
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin-17_receptor
Protein-coding gene in the species Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin 13 receptor, alpha 1
Interleukin_13_receptor,_alpha_1
Type II cytokine receptor
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interferon-lambda_receptor
Mammalian protein found in Homo sapiens
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin
Interleukin_8_receptor,_beta
travel, tourism, insurance
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
SARILUMAB
travel, tourism, insurance